Cargando…
Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: A prospective study
BACKGROUND: The contraceptive skin patch (CSP) accepted by the U.S. FDA in 2001 includes ethinylestradiol and norelgestromine, whereas the subdermal contraceptive implant (SCI) has etonogestrel and is also approved by the FDA. In Mexico, both are now widely used for contraception but their effects o...
Autores principales: | Hernandez-Juarez, Jesus, Garcia-Latorre, Ethel A, Moreno-Hernandez, Manuel, Moran-Perez, Jose Fernando, Rodriguez-Escobedo, Miguel Angel, Cogque-Hernandez, Gerardo, Julián-Nacer, Rubén, Hernandez-Giron, Xochitl, Palafox-Gomez, Rosalia, Isordia-Salas, Irma, Majluf-Cruz, Abraham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044294/ https://www.ncbi.nlm.nih.gov/pubmed/24767248 http://dx.doi.org/10.1186/1742-4755-11-33 |
Ejemplares similares
-
Migration of a contraceptive subdermal device into the lung
por: Choi, Ji Hui, et al.
Publicado: (2017) -
Migration of a Contraceptive Subdermal Device Into the Lung
por: Enabi, Joud, et al.
Publicado: (2023) -
Experiences of localization and removal of non-palpable subdermal contraceptive implants with ultrasound
por: Kim, SooHyun, et al.
Publicado: (2019) -
Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant
por: Ali, Moazzam, et al.
Publicado: (2016) -
Cystathionine β-synthase and methylenetetrahydrofolate reductase mutations in Mexican individuals with hyperhomocysteinemia
por: Figueroa-Torres, Anahi Guadalupe, et al.
Publicado: (2020)